Sign in

CIK 0001703057 · Large accelerated filer

AbCellera Biologics Inc.

Sign in to watch
Ticker
ABCL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(604) 559-9005
Business address
150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
  1. 4 Conversion 10% owner acquired 29,105,761 shares (conversion)
  2. 3/A Insider 3/A
  3. 4 Open-market buy Director bought 3,000,000 shares at $20.00 ($60,000,000)
  4. 4 Conversion Director acquired 29,105,761 shares (conversion)
  5. 4 Open-market buy Director bought 25,000 shares at $20.00 ($500,000)
  6. 4 Open-market buy Chief Operating Officer bought 23,000 shares at $20.00 ($460,000)
  7. 4 Open-market buy Director bought 73,665 shares at $20.00 ($1,473,300)
  8. 4 Open-market buy Chief Legal Officer bought 500 shares at $20.00 ($10,000)
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 424B4 Offering Prospectus
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 15 of 17 · 325 filings